CA2205442C - Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants - Google Patents

Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants Download PDF

Info

Publication number
CA2205442C
CA2205442C CA002205442A CA2205442A CA2205442C CA 2205442 C CA2205442 C CA 2205442C CA 002205442 A CA002205442 A CA 002205442A CA 2205442 A CA2205442 A CA 2205442A CA 2205442 C CA2205442 C CA 2205442C
Authority
CA
Canada
Prior art keywords
nsaid
gum
composition
weight
aspirin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002205442A
Other languages
English (en)
French (fr)
Other versions
CA2205442A1 (en
Inventor
David R. Friend
Karen Yu
Jagdish Parasrampuria
Eric H. Kuhrts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amarin Development AB
Original Assignee
Amarin Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amarin Development AB filed Critical Amarin Development AB
Publication of CA2205442A1 publication Critical patent/CA2205442A1/en
Application granted granted Critical
Publication of CA2205442C publication Critical patent/CA2205442C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA002205442A 1994-12-01 1995-11-30 Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants Expired - Fee Related CA2205442C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34760194A 1994-12-01 1994-12-01
US08/347,601 1994-12-01
PCT/US1995/015599 WO1996016639A1 (en) 1994-12-01 1995-11-30 Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants

Publications (2)

Publication Number Publication Date
CA2205442A1 CA2205442A1 (en) 1996-06-06
CA2205442C true CA2205442C (en) 2003-01-21

Family

ID=23364417

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002205442A Expired - Fee Related CA2205442C (en) 1994-12-01 1995-11-30 Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants

Country Status (8)

Country Link
EP (1) EP0804169A4 (de)
JP (1) JPH10509982A (de)
AU (1) AU690417B2 (de)
CA (1) CA2205442C (de)
FI (1) FI972305A0 (de)
MX (1) MX9704079A (de)
NO (1) NO972485L (de)
WO (1) WO1996016639A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
EP0859603B1 (de) * 1996-07-08 2008-12-17 Penwest Pharmaceuticals Co. Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
RU2260424C9 (ru) * 1998-08-21 2006-05-20 Новартис Аг Новая композиция для перорального введения
ES2257869T3 (es) * 1998-08-21 2006-08-01 Novartis Ag Nueva formulacion oral para agonistas o antagonistas de 5-ht4.
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers
BR112022010672A2 (pt) * 2019-12-05 2022-08-16 Flagship Pioneering Innovations V Inc Agentes ativos acilados e métodos de seu uso para o tratamento de distúrbios metabólicos e doença hepática gordurosa não alcoólica
JP7782842B2 (ja) * 2022-06-02 2025-12-09 株式会社パウレック 速崩壊性圧縮成形物の製造方法および速崩壊性圧縮成形物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327938A (en) * 1969-12-17 1973-08-22 Sucrest Corp Composition for use in forming tablets
DE2130545A1 (de) * 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper
EP0222883A1 (de) * 1985-05-15 1987-05-27 Riker Laboratories, Inc. Theophyllinarzneimittel mit verzögerter freigabe sowie verfahren zu deren herstellung
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
EP0676967A4 (de) * 1992-12-30 1996-10-02 Fmc Corp Leicht verfügbarer hilfsstoff zur verzögerten freisetzung auf der basis von konjac glukomannan.

Also Published As

Publication number Publication date
EP0804169A4 (de) 1998-08-19
WO1996016639A1 (en) 1996-06-06
JPH10509982A (ja) 1998-09-29
AU690417B2 (en) 1998-04-23
CA2205442A1 (en) 1996-06-06
NO972485L (no) 1997-07-31
AU4595196A (en) 1996-06-19
FI972305A7 (fi) 1997-05-30
NO972485D0 (no) 1997-05-30
MX9704079A (es) 1997-12-31
FI972305L (fi) 1997-05-30
FI972305A0 (fi) 1997-05-30
EP0804169A1 (de) 1997-11-05

Similar Documents

Publication Publication Date Title
US5023245A (en) Improved niacin formulation
EP0234670B1 (de) Xanthangummienthaltende Arzneimittelformulierung mit verzögerter Freisetzung
US4983398A (en) Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
US5096714A (en) Prolonged release drug tablet formulations
CA2301132C (en) Rapidly disintegrating methylcellulose tablets
AU772891B2 (en) Sustained release tablet containing hydrocolloid and cellulose ether
US5445826A (en) Delivery system containing a gel-forming dietary fiber and a drug
AU690417B2 (en) Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
US5993860A (en) NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
AU709413B2 (en) Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants
MXPA97004043A (en) Assortment of pharmacy of sustained release using a rubber of hydrocoloid in powder obtained from top plants
AU744483B2 (en) Compressed compositions comprising clarified xanthan gum
CA2030448A1 (en) Niacin drink mix formulation
JP2026031482A (ja) 球状吸着炭を含有する新規なジェリー製剤
CA2030449A1 (en) Prolonged release drug tablet formulations
AU2009200874A1 (en) Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
MXPA00001856A (en) Rapidly disintegrating methylcellulose tablets
MXPA00001857A (en) Rapidly disintegrating methylcellulose tablets
MXPA01006202A (es) Formulacion de liberacion controlada de sodio de divalproex
CA2543223A1 (en) Rapidly disintegrating methylcellulose tablets

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed